Hye Won Kwak
Overview
Explore the profile of Hye Won Kwak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee Y, Cheong M, Lee J, Bang E, Park S, Park H, et al.
Vaccine
. 2024 Nov;
43(Pt 2):126518.
PMID: 39547049
Zika virus (ZIKV) infection is primarily transmitted by mosquitoes and often asymptomatic in most individuals. Infection during pregnancy can lead to severe birth defects such as congenital microcephaly, and currently,...
2.
Lee S, Yoon H, Hong S, Kwon S, Hong J, Kwak H, et al.
J Med Virol
. 2023 Dec;
95(12):e29309.
PMID: 38100632
The E6 and E7 proteins of specific subtypes of human papillomavirus (HPV), including HPV 16 and 18, are highly associated with cervical cancer as they modulate cell cycle regulation. The...
3.
Park S, Park S, Lee K, Kwak H, Kim Y, Park H, et al.
Vaccine
. 2023 Dec;
42(2):69-74.
PMID: 38097457
Background: As the nasal mucosa is the initial site of infection for COVID-19, intranasal vaccines are more favorable than conventional vaccines. In recent clinical studies, intranasal immunization has been shown...
4.
Kim J, Jeon K, Park S, Bang Y, Park H, Kwak H, et al.
NPJ Vaccines
. 2023 Nov;
8(1):167.
PMID: 37907507
We developed a promising mRNA vaccine against severe fever with thrombocytopenia syndrome (SFTS), an infectious disease caused by the SFTS virus that is primarily transmitted through tick bites. Administration of...
5.
Kwak H, Park H, Jung S, Oh E, Park S, Kim Y, et al.
Vaccine
. 2023 Oct;
41(47):7033.
PMID: 37863670
No abstract available.
6.
Lee Y, Bang Y, Yoo S, Park S, Park H, Kwak H, et al.
J Infect Dis
. 2023 Sep;
229(5):1408-1418.
PMID: 37711050
Developing new adjuvants that can effectively induce humoral and cellular immune responses while broadening the immune response is of great value. In this study, we aimed to develop single-stranded RNA...
7.
Park H, Bang Y, Kwon S, Kwak W, Park S, Roh G, et al.
NPJ Vaccines
. 2023 Jun;
8(1):84.
PMID: 37271785
In response to the COVID-19 pandemic, different types of vaccines, such as inactive, live-attenuated, messenger RNA (mRNA), and protein subunit, have been developed against SARS-CoV-2. This has unintentionally created a...
8.
Kim J, Jeon K, Hong J, Park S, Cho H, Park H, et al.
Sci Rep
. 2023 May;
13(1):8189.
PMID: 37210393
Severe fever with thrombocytopenia syndrome virus was first discovered in 2009 as the causative agent of severe fever with thrombocytopenia syndrome. Despite its potential threat to public health, no prophylactic...
9.
Kwak H, Park H, Jung S, Oh E, Park S, Kim Y, et al.
Vaccine
. 2023 Feb;
41(11):1892-1901.
PMID: 36792434
Owing to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants, the development of effective and safe vaccines has become a priority. The measles virus...
10.
Kwak H, Hong S, Park H, Park H, Bang Y, Kim J, et al.
BMC Cancer
. 2022 Oct;
22(1):1041.
PMID: 36199130
Background: Adjuvant therapies such as radiation therapy, chemotherapy, and immunotherapy are usually given after cancer surgery to improve the survival of cancer patients. However, despite advances in several adjuvant therapies,...